4DMedical

4DMedical progresses to a commercial agreement with Qscan

Respiratory imaging technology company 4DMedical Limited (ASX:4DX, “4DMedical”, or the “Company”) today announces the signing of a commercial contract with Qscan Radiology Clinics ("Qscan"), a leading provider of diagnostic imaging services in Queensland. This agreement follows a successful pilot of 4DMedical’s products with Qscan, and represents the first Australian contract to incorporate products from both the Pulmonary Function and Pulmonary Structure suites, including CT LVAS™.


Pilot success leads to commercial agreement

With 40 clinics across Queensland, New South Wales, ACT, Tasmania, and Western Australia, Qscan is one of Australia’s leading medical imaging providers, offering a comprehensive range of diagnostic and interventional radiology services.

Following the success of a pilot program, which demonstrated the clinical and operational effectiveness of 4DMedical’s proprietary suite of products, 4DMedical and Qscan have entered a commercial arrangement under which Qscan will offer 4DMedical’s respiratory imaging solutions at select practices in Brisbane.

This agreement marks 4DMedical’s first Australian commercial contract to incorporate products from both its Pulmonary Function and Pulmonary Structure suites. Specifically, the agreement with Qscan will provide clinicians with access to CT LVAS™, Lung Density Analysis™ - Inspiration (LDAi), Functional Lung Density Analysis™ (LDAf), and Lung Texture Analysis™ (LTA), each providing advanced diagnostic capabilities to support referrers and patients.

Reports will be delivered and billed on a Software-as-a-Service model on terms in line with those of the Company’s other commercial partners.

4DMedical MD/CEO and Founder Andreas Fouras said:

Having completed our pilot with Qscan, we are excited to have progressed to a commercial agreement. This partnership ensures that more patients and clinicians have access to detailed, actionable insights into lung health, supporting better healthcare outcomes.

Momentum continues to build with the commercialisation of our technology across the US and Australia. With the addition of Qscan to our network of providers in Australia, I am excited to see our footprint expand to ensure our cutting-edge technology is now becoming more readily available to all Australians.


Click here for the full ASX Release

This article includes content from 4DMedical, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

The Conversation (0)
Man holding magnifying glass.

Tech 5: CoreWeave IPO Falls Short, OpenAI Close to Completing US$40 Billion Funding Round

This week brought a fresh set of challenges to the tech sector, beginning with an announcement from the US Bureau of Industry and Security on Tuesday (March 25) of new export restrictions targeting 80 companies across Asia and the Middle East, impacting some of Big Tech’s key customers.

Consumer confidence weakened, further dampening market sentiment.

This was evidenced by the release of the Conference Board’s Consumer Confidence Index report on Tuesday, and the University of Michigan’s consumer sentiment survey, released on Friday (March 28).

Keep reading...Show less
Hand holding an AI chip.

Global AI Stocks: 9 Biggest Companies in 2025

As the artificial intelligence (AI) market continues to grow, there are many AI stocks for investors to choose from on top exchanges like the NASDAQ, TSX and ASX.

AI technology has made strong inroads into several key industries, including logistics, manufacturing, finance, healthcare, customer service and cybersecurity.

The technology has been around for a long time, but this current wave of buzz comes after the release of OpenAI’s ChatGPT, a generative AI platform. This intelligent chatbot shows how quickly generative AI is advancing, and it has led to many other major tech firms entering the space with their own generative AI offerings or including AI technology into their innovative products.

Keep reading...Show less
RocketBoots

RocketBoots Partners with Global POS Software Vendor to Drive Customer Markets Penetration

Artificial Intelligence software company, RocketBoots Limited (ASX:ROC) (RocketBoots or the Company), is pleased to announce the signing of a partnership agreement with global point-of-sale (POS) vendor, GEBIT Solutions GmbH (Gebit).

Keep reading...Show less
AI chip.

Tech 5: CoreWeave Sets IPO Date, Google to Acquire Wiz

The tech landscape presented a dichotomy this week: company growth juxtaposed with market volatility over concerns that US President Donald Trump’s tariffs could upend global trade and lead to a recession.

“Inflation has started to move up,” US Federal Reserve Chair Jerome Powell said after a two day meeting that culminated in the interest rate target remaining between 4.25 and 4.5 percent.

“There may be a delay in further progress over the course of this year,” he added.

Keep reading...Show less
Decidr AI Industries

AWS Strategic Partnership & Equity Raising

Decidr AI Industries Ltd (ASX: DAI) (“the Company”), is pleased to announce that Decidr.ai Pty Ltd (“Decidr”) has engaged in a multi-part strategic partnership with Amazon Web Services (“AWS”) to accelerate AI-powered business transformation and the adoption of Decidr Agentic technology.

Keep reading...Show less

Latest Press Releases

Related News

×